Forecasting the number of applications expected for five substances added the Authorisation List
ECHA has published a report forecasting the number of applications expected for five substances added to the Authorisation List on 8 April 2022.
The report estimates that ECHA should receive 12 to 23 applications in 2023. It also investigates the availability of potential alternatives.
ECHA conducted similar work in 2019 for 11 substances that were added to the Authorisation List in 2020.
Report | Official Journal
Assessment of regulatory needs reports published
Reports have been published for the following groups of substances:
-
dialkyl (and diaryl) dithiophosphates (DDPs);
-
esters from branched or non-aromatic cyclic dicarboxylic acids and aliphatic alcohols;
-
imidazoles;
-
N-alkoxy-2,2,6,6-tetramethylpiperidine derivatives;
-
phthalic anhydrides and hydrogenated phthalic anhydrides; and
-
simple lithium compounds.
You can filter the list with the group name to get a full list of the substances in the group and access the report.
Assessment of regulatory needs list
Committees’ opinions on a restriction available
The consolidated opinions of the Committees for Risk Assessment and Socio-Economic Analysis on a proposal to restrict substances in single-use baby diapers submitted by France are available.
Registry of restriction intentions until outcome
Commission decisions on applications for authorisation
The European Commission has granted four authorisations for uses of 4-nonylphenol, branched and linear, ethoxilated (4-NPnEO) (EC -, CAS -) (review period expiry dates are in brackets):
-
one use applied for by DiaSorin S.p.A. (4 January 2033);
-
one use applied by BioMérieux SA (4 January 2025);
-
one use applied for by Hospira Zagreb d.o.o. (4 January 2033); and
-
one use applied for by DIAGAST (4 January 2033).
|
